Clinical Trial Update: V503 in Chinese Girls 9-14 Years Old Versus Chinese Women 20-26 Years Old (V503-071) [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing V503 in Chinese girls 9-14 with Chinese women 20-26 for papillomavirus infections; study status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillomavirus Infections

Drugs mentioned

• V503

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Papillomavirus Infections | Phase 3 | Status: ACTIVE_NOT_RECRUITING